4,901 trials
Infection, Human Immunodeficiency Virus · HIV Infections
Primary: Number of Subjects With Anti-V1V2 Total Immunoglobulin G (IgG) Binding Antibody Multiplex Assay (BAMA) Response Call — 25; 15; 8; 20 Participants
Tuberculosis
Primary: Number of Participants With Adverse Events — 22; 20; 24; 10 participants
Healthy Volunteers
Primary: AUClast: Area Under the Serum Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Vedolizumab SC — 492.6; 455.4 microgram*day per…
Type 1 Diabetes · Type 2 Diabetes
Primary: Number of Participants Who Experienced Adverse Events — 1; 7 participants
Tuberculosis
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 14; 6; 0; 0 Participants
Type 1 Diabetes Mellitus · Type 2 Diabetes Mellitus
Primary: Number of Participants Who Experienced an Adverse Event (AE) — 1; 1; 4; 3 Participants
Chronic Pain
Primary: Cmax of OTR Tablet 40 mg and OXYCONTIN Tablet 40 mg in a Fed State — 86.15; 63.54 ng/ml
Topical Anaesthesia
Primary: VAS in Healthy Participants, When Topical 5% Lidocaine Dental Gel Was Applied to the Upper Palatal and Upper Anterior Buccal Sulcus Areas With a Microneedle Patch and a…
Neoplasms by Histologic Type
Primary: Number of Solid Tumor Participants With First-Cycle Dose-Limiting Toxicity (DLT) — 0; 0; 0; 1 participants
Locally Advanced, Metastatic Solid Tumors
Primary: Number of Participants Who Experienced a Dose Limiting Toxicity (DLT) During Cycle 1 — 1; 2; 1; 1 Participants
Malaria
Primary: Safety and Tolerability of Administration of R21 With and Without the Adjuvant Matrix-M1 Assessed by the Occurrence of Solicited Local and Systemic Adverse Events…
Rheumatoid Arthritis
Primary: Localization of Tc 99m Tilmanocept by Planar and SPECT/CT Imaging in Subjects With Active RA and Concordance With Swollen/Tender Joints — 0; 0; 30; 35 Joints
Healthy
Primary: Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞). — 7013.010; 7261.119; 7649.491…
Herpes Zoster
Primary: Part 1: Geometric Mean Fold Rise of the Varicella-Zoster Virus (VZV)-Specific Immune Responses Measured by Glycoprotein Enzyme-Linked Immunosorbent Assay in…
Atopic Dermatitis Eczema
Primary: Relative Abundance of Staphylococcus Aureus Compared to Baseline — 0.106; 12.9 Relative abundance of S. aureus